Home LiteratureArticle Details
PMID: 12654836 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine.

Infection and immunity ·Vol. 71 ·No. 4 ·2003-04-00 ·Pages 2142-52

Møller AK, Leatham MP, Conway T, Nuijten PJ, de Haan LA, Krogfelt KA, Cohen PS

Abstract

The ability of E. coli strains to colonize the mouse large intestine has been correlated with their ability to grow in cecal and colonic mucus. In the present study, an E. coli MG1655 strain was mutagenized with a mini-Tn5 Km (kanamycin) transposon, and mutants were tested for the ability to grow on agar plates with mouse cecal mucus as the sole source of carbon and nitrogen. One mutant, designated MD42 (for mucus defective), grew poorly on cecal-mucus agar plates but grew well on Luria agar plates and on glucose minimal-agar plates. Sequencing revealed that the insertion in MD42 was in the waaQ gene, which is involved in lipopolysaccharide (LPS) core biosynthesis. Like "deep-rough" E. coli mutants, MD42 was hypersensitive to sodium dodecyl sulfate (SDS), bile salts, and the hydrophobic antibiotic novobiocin. Furthermore, its LPS core oligosaccharide was truncated, like that of a deep-rough mutant. MD42 initially grew in the large intestines of streptomycin-treated mice but then failed to colonize (<10(2) CFU per g of feces), whereas its parent colonized at levels between 10(7) and 10(8) CFU per g of feces. When mouse cecal mucosal sections were hybridized with an E. coli-specific rRNA probe, MD42 was observed in cecal mucus as clumps 24 h postfeeding, whereas its parent was present almost exclusively as single cells, suggesting that clumping may play a role in preventing MD42 colonization. Surprisingly, MD42 grew nearly as well as its parent during growth in undiluted, highly viscous cecal mucus isolated directly from the mouse cecum and, like its parent, survived well after reaching stationary phase, suggesting that there are no antimicrobials in mucus that prevent MD42 colonization. After mini-mariner transposon mutagenesis, an SDS-resistant suppressor mutant of MD42 was isolated. The mini-mariner insertion was shown to be in the bipA gene, a known regulator of E. coli surface components. When grown in Luria broth, the LPS core of the suppressor mutant remained truncated; however, the LPS core was not truncated when the suppressor mutant was grown in the presence of SDS. Moreover, when the suppressor mutant was grown in the presence of SDS and fed to mice, it colonized the mouse large intestine. Collectively, the data presented here suggest that BipA may play a role in E. coli MG1655 LPS core biosynthesis and that because MD42 forms clumps in intestinal mucus, it is unable to colonize the mouse large intestine.

MeSH Terms
Animals Cecum/microbiology Culture Media DNA Transposable Elements Escherichia coli/genetics,growth & development Escherichia coli Proteins/genetics,metabolism GTP Phosphohydrolases/genetics,metabolism Glycosyltransferases/genetics,metabolism Intestinal Mucosa/microbiology Intestine, Large/microbiology Lipopolysaccharides/metabolism Male Mice Mutation Phosphoproteins/genetics,metabolism
Chemicals
Culture Media DNA Transposable Elements Escherichia coli Proteins Lipopolysaccharides Phosphoproteins Glycosyltransferases WaaQ protein, E coli GTP Phosphohydrolases typA protein, E coli
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Møller Annette K
Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA.
Leatham Mary P
Conway Tyrrell
Nuijten Piet J M
de Haan Louise A M
Krogfelt Karen A
Cohen Paul S
References (45)
45 references, click to expand
  1. Investigation of minor components of Escherichia coli type 1 fimbriae: protein chemical and immunological aspects.
    Microb Pathog. 1988 Mar;4(3):231-8 PMID: 2904111
  2. Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice.
    Infect Immun. 1988 Sep;56(9):2209-17 PMID: 3044995
  3. Neither motility nor chemotaxis plays a role in the ability of Escherichia coli F-18 to colonize the streptomycin-treated mouse large intestine.
    Infect Immun. 1990 Sep;58(9):2957-61 PMID: 2201640
  4. Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.
    J Bacteriol. 1990 Nov;172(11):6568-72 PMID: 2172217
  5. Effect of rfaH (sfrB) and temperature on expression of rfa genes of Escherichia coli K-12.
    J Bacteriol. 1991 Oct;173(20):6428-31 PMID: 1655711
  6. Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice.
    Infect Immun. 1993 Dec;61(12):5029-34 PMID: 8225579
  7. Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization.
    Infect Immun. 1994 Nov;62(11):5191-4 PMID: 7927805
  8. Role of leuX in Escherichia coli colonization of the streptomycin-treated mouse large intestine.
    Microb Pathog. 1994 Nov;17(5):301-11 PMID: 7723657
  9. Bacterial adhesion to and penetration of intestinal mucus in vitro.
    Methods Enzymol. 1995;253:309-14 PMID: 7476395
  10. Salmonella typhimurium responses to a bactericidal protein from human neutrophils.
    Mol Microbiol. 1995 Aug;17(3):523-31 PMID: 8559071
  11. Conditionally replicative and conjugative plasmids carrying lacZ alpha for cloning, mutagenesis, and allele replacement in bacteria.
    Plasmid. 1996 Jan;35(1):1-13 PMID: 8693022
  12. The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine.
    Infect Immun. 1996 Sep;64(9):3497-503 PMID: 8751890
  13. Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine.
    Infect Immun. 1996 Sep;64(9):3504-11 PMID: 8751891
  14. Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization.
    Infect Immun. 1996 Sep;64(9):3811-7 PMID: 8751933
  15. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization.
    Mol Microbiol. 1998 Feb;27(4):797-805 PMID: 9515705
  16. BipA: a tyrosine-phosphorylated GTPase that mediates interactions between enteropathogenic Escherichia coli (EPEC) and epithelial cells.
    Mol Microbiol. 1998 Apr;28(2):265-79 PMID: 9622352
  17. Involvement of waaY, waaQ, and waaP in the modification of Escherichia coli lipopolysaccharide and their role in the formation of a stable outer membrane.
    J Biol Chem. 1998 Oct 9;273(41):26310-6 PMID: 9756860
  18. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica.
    Mol Microbiol. 1998 Oct;30(2):221-32 PMID: 9791168
  19. Vibrio cholerae intestinal population dynamics in the suckling mouse model of infection.
    Infect Immun. 1999 Aug;67(8):3733-9 PMID: 10417131
  20. Molecular switches--the ON and OFF of bacterial phase variation.
    Mol Microbiol. 1999 Sep;33(5):919-32 PMID: 10476027
  21. Cell population kinetics in the intestinal epithelium of the mouse.
    Exp Cell Res. 1959 Jun;17(3):420-38 PMID: 13672199
  22. The fertility of Escherichia coli antigen test strains in crosses with K 12.
    Acta Pathol Microbiol Scand. 1961;51:280-90 PMID: 13731304
  23. CHANGES IN THE MOUSE'S ENTERIC MICROFLORA ASSOCIATED WITH ENHANCED SUSCEPTIBILITY TO SALMONELLA INFECTION FOLLOWING STREPTOMYCIN TREATMENT.
    J Infect Dis. 1963 Jul-Aug;113:59-66 PMID: 14044094
  24. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus.
    Infect Immun. 1988 May;56(5):1030-5 PMID: 3281898
  25. Regulation of the Escherichia coli K5 capsule gene cluster: evidence for the roles of H-NS, BipA, and integration host factor in regulation of group 2 capsule gene clusters in pathogenic E. coli.
    J Bacteriol. 2000 May;182(10):2741-5 PMID: 10781541
  26. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
    Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5 PMID: 10829079
  27. Genetic footprinting with mariner-based transposition in Pseudomonas aeruginosa.
    Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10191-6 PMID: 10963681
  28. Mutation of the lipopolysaccharide core glycosyltransferase encoded by waaG destabilizes the outer membrane of Escherichia coli by interfering with core phosphorylation.
    J Bacteriol. 2000 Oct;182(19):5620-3 PMID: 10986272
  29. Purification and characterization of WaaP from Escherichia coli, a lipopolysaccharide kinase essential for outer membrane stability.
    J Biol Chem. 2001 Feb 23;276(8):5498-504 PMID: 11069912
  30. Inhibition of Escherichia coli precursor-16S rRNA processing by mouse intestinal contents.
    Environ Microbiol. 1999 Feb;1(1):23-32 PMID: 11207715
  31. BipA is required for growth of Escherichia coi K12 at low temperature.
    Mol Genet Genomics. 2001 Oct;266(2):313-7 PMID: 11683274
  32. Identification of novel factors involved in colonization and acid tolerance of Vibrio cholerae.
    Mol Microbiol. 2002 Mar;43(6):1471-91 PMID: 11952899
  33. Restriction of nonglucosylated T-even bacteriophage: properties of permissive mutants of Escherichia coli B and K12.
    Virology. 1967 Apr;31(4):688-701 PMID: 4290282
  34. (1-14C)glucosamine incorporation by subcellular fractions of small intestinal mucosa. Identification by precursor labeling of three functionally distinct glycoprotein classes.
    J Biol Chem. 1970 Jul 25;245(14):3584-92 PMID: 5470824
  35. Acute undifferentiated human diarrhea in the tropics. II. Alterations in intestinal fluid and electrolyte movements.
    J Clin Invest. 1971 Apr;50(4):890-900 PMID: 4926261
  36. Human fecal flora: the normal flora of 20 Japanese-Hawaiians.
    Appl Microbiol. 1974 May;27(5):961-79 PMID: 4598229
  37. Ultrastructure of cell loss in intestinal mucosa.
    J Ultrastruct Res. 1977 Aug;60(2):272-7 PMID: 886645
  38. Lipid composition of the gastric mucous barrier in the rat.
    J Biol Chem. 1978 Jun 10;253(11):3785-91 PMID: 649606
  39. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
    Anal Biochem. 1982 Jan 1;119(1):115-9 PMID: 6176137
  40. Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora.
    Infect Immun. 1983 Feb;39(2):676-85 PMID: 6339388
  41. Survival and implantation of Escherichia coli in the intestinal tract.
    Infect Immun. 1983 Feb;39(2):686-703 PMID: 6339389
  42. DNA sequence adjacent to flagellar genes and evolution of flagellar-phase variation.
    J Bacteriol. 1983 Jul;155(1):74-81 PMID: 6305924
  43. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli.
    EMBO J. 1986 Jun;5(6):1389-93 PMID: 2874022
  44. Plasmid vector pBR322 and its special-purpose derivatives--a review.
    Gene. 1986;50(1-3):3-40 PMID: 3034735
  45. Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.
    Infect Immun. 1989 Oct;57(10):3022-9 PMID: 2570752
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2003-04-00
Pages
2142-52
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC152069
Subset
IM
Grants
NIAID NIH HHS · R01 AI048945 · United States
NIAID NIH HHS · R56 AI048945 · United States
NIAID NIH HHS · AI 48945 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]